XML 60 R72.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
14. Segment Reporting (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Segment Reporting Information [Line Items]      
Number Of Products And Services 9,000    
Net sales $ 2,311,700 $ 2,289,400 $ 2,160,200
Interest expense 23,416 23,962 23,014
Depreciation and amortization 134,200 138,100 148,700
Segment profit 229,661 (103,341) 119,250
Total assets 8,008,859 5,611,068  
Payments to Acquire Property, Plant, and Equipment 98,532 129,825 111,332
Life Science [Member]      
Segment Reporting Information [Line Items]      
Net sales 885,900 861,700 785,200
Interest expense 7,400 7,200 7,000
Depreciation and amortization 29,400 34,100 36,200
Segment profit 72,100 28,700 (9,900)
Total assets 496,100 450,200  
Payments to Acquire Property, Plant, and Equipment 16,600 36,700  
Clinical Diagnostics [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,412,000 1,411,800 1,360,800
Interest expense 15,900 16,700 14,900
Depreciation and amortization 71,700 72,000 80,200
Segment profit 148,500 (145,700) 114,800
Total assets 1,075,800 949,000  
Payments to Acquire Property, Plant, and Equipment 58,900 60,500  
All Other Segments [Member]      
Segment Reporting Information [Line Items]      
Net sales 13,800 15,900 14,200
Interest expense 100 100 0
Depreciation and amortization 900 500 0
Segment profit (1,500) 200 $ 1,400
Total assets 9,200 5,900  
Payments to Acquire Property, Plant, and Equipment $ 600 $ 500